Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Leonidas
Leonidas Bleris, Allen, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100197006 | MOLECULAR CIRCUITS - Disclosed herein are autonomous molecular circuits that can function in cells. The circuits can process logical operations in which one or more input cues are among the operands and produce an appropriate output. Such circuits can be implemented in living cells, e.g., eukaryotic or prokaryotic cells that have been modified to include circuit components. The molecular circuits and cells containing the circuits can be used in a variety of applications including, e.g., diagnostics, therapeutics, and protein production. | 08-05-2010 |
Leonidas Delgiannidis, Lexington, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090325699 | INTERFACING WITH VIRTUAL REALITY - Included are embodiments for implementing virtual reality. More specifically, one embodiment of a virtual reality method includes interfacing with host game logic, the host game logic configured to provide an interactive video game interface and receiving display data from the host game logic, and provide the display data to a virtual reality head mounted display. Some embodiments include receiving user motion input to control at least a portion of the interactive video game interface, the user motion too input being provided via a virtual simulation device, the virtual simulation device configured to facilitate control of at least a portion of the interactive video game interface via simulation of user motion and translating the received user motion input into a format for controlling the interactive video game interface. Still some embodiments include providing the translated user motion input to the host game logic. | 12-31-2009 |
Leonidas Kiliaris, Lincoln Park, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20100305798 | System And Method For Vehicle Drive Cycle Determination And Energy Management - System and method for vehicle drive cycle determination and energy management is provided. Based on a number of inputs, the system can determine the type of road that the vehicle is likely to drive on as well as the level of traffic congestion that the vehicle is likely to experience. Using these determinations, setpoints for various degrees of freedom, such as engine speed and battery power, can be set to reduce energy usage in the vehicle. | 12-02-2010 |
Leonidas Kiriazis, Munster DE
| Patent application number | Description | Published |
|---|---|---|
| 20090130401 | DECORATED TRIM ELEMENT - A trim element for the passenger compartment of a motor vehicle, comprising a substrate and a film bonded to it, the film consisting of polypropylene (PP) or a polypropylene copolymer. | 05-21-2009 |
Leonidas Ntziachristos, Thessaloniki GR
| Patent application number | Description | Published |
|---|---|---|
| 20100058878 | DILUTER FOR EXHAUST GAS SAMPLING AND METHOD THEREFOR - The present invention relates to a device used for the dilution of exhaust gas (diluter) and in particular for engines or vehicles. More particularly, the invention relates to a device and a method which may maintain a constant dilution ratio regardless of the exhaust gas backpressure in the exhaust line, without using any moving parts. The proposed diluter utilizes a very small fraction of the exhaust gas, sampled through a capillary duct, simply immersed to the exhaust flow, which is otherwise freely exhausting to the atmosphere. The sample flowrate through the capillary is achieved by maintaining a regulated underpressure at the capillary outlet. The diluted exhaust is then collected in a stabilization chamber, where temperature, humidity and residence time may be adjusted to condition the collected aerosol at will. Multiple capillaries and stabilization chambers may be cascaded to increase the dilution ratios. After the final dilution stage, particle samples may be collected on a filter for gravimetric determination or analyzed by number counters, surface monitors or any other technique utilized for the physical or chemical characterization of particles. In a preferred embodiment the capillary duct is realized with a hypodermic needle and two cascaded hypodermic needles/stabilization chambers are combined to provide the desired dilution ratio. In another embodiment, exhaust gas may be led to the diluter's capillary duct by means of two probes, located respectively upstream and downstream of any aftertreatment device, which needs to be characterized. By means of shut-off valves, exhaust gas may be fed to the diluter's capillary by either the upstream or the downstream probe, thus providing an estimate of the filtration efficiency of the device. | 03-11-2010 |
Leonidas Stamatatos, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080248063 | Hetero-Oligomeric Hiv Envelope Proteins - In one aspect, the invention provides an HIV envelope heterotrimer comprising at least two different Env glycoprotein monomers. In some heterotrimers, at least two Env glycoprotein monomers are from different HIV isolates, for example, different HIV-1 isolates. Heterotrimers may contain Env glycoprotein monomers from HIV isolates belonging to the same clade or to different clades or both. At least one of the Env glycoprotein monomers in a heterotrimer of the invention may be modified in a way that alters its amino acid composition. In another aspect, the invention provides methods for inducing an immune response in a vertebrate host against HIV or an HIV-infected cell, comprising administering to a vertebrate host a prophylactically or therapeutically effective amount of a composition comprising an HIV envelope heterotrimer. | 10-09-2008 |
| 20080267993 | AIDS vaccines - The invention provides vaccination protocols for administering immunogens to a primate host in order to promote the formation of neutralizing antibodies (NAbs) against primate immunodeficiency viruses. In some embodiments, the vaccination protocols comprise the step of administering to a primate host a first immunogen comprising at least one primate immunodeficiency virus Envelope (env) sequence having a first set of consensus glycosylation sequences, followed by a second immunogen comprising at least one primate immunodeficiency virus env sequence having a second set of consensus glycosylation sequences, wherein the differences between the first set of consensus glycosylation sequences and the second set of consensus glycosylation sequences comprise differences in consensus glycosylation sequences observed in HIV isolates obtained at different time points of a natural infection. | 10-30-2008 |